Tudor Investment Corp’s Filana Therapeutics FLNA Stock Holding History

Tudor Investment Corp’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,910	Closed	-$744K	–	2757
2021 Q2	$761K	Buy	+8,910	New	+$477K	0.01%	977

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Tudor Investment Corp's FLNA Position: Q3 2021 in Review

Tudor Investment Corp sold out of Filana Therapeutics (FLNA) in Q3 2021, closing a stake of 8,910 shares — an estimated $744K sold.

Tudor Investment Corp first reported a position in FLNA in Q2 2021 and held it in 1 quarter. The position peaked at $761K in Q2 2021. 180 funds tracked by Wall St. Rank hold FLNA as of Q3 2021.

Tudor Investment Corp reported no remaining Filana Therapeutics position as of Q3 2021 after selling out during the quarter.
Tudor Investment Corp sold 8,910 Filana Therapeutics shares in Q3 2021, an estimated $744K.
Tudor Investment Corp first reported a position in Filana Therapeutics in Q2 2021 and held it in 1 quarter.
Tudor Investment Corp's Filana Therapeutics position peaked at $761K in Q2 2021.
180 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2021.

Based on Tudor Investment Corp's 13F filing for Q3 2021, filed 15 Nov 2021.